Structural studies on Plasmodium vivax merozoite surface protein-1.

[1]  Ute Woehlbier,et al.  Interactions between Merozoite Surface Proteins 1, 6, and 7 of the Malaria Parasite Plasmodium falciparum* , 2006, Journal of Biological Chemistry.

[2]  H. D. del Portillo,et al.  A Reduced Risk of Infection with Plasmodium vivax and Clinical Protection against Malaria Are Associated with Antibodies against the N Terminus but Not the C Terminus of Merozoite Surface Protein 1 , 2006, Infection and Immunity.

[3]  David L Smith,et al.  A high-throughput method for quantifying alleles and haplotypes of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-1 19 kDa , 2006, Malaria Journal.

[4]  Steven S. Oh,et al.  Two Plasmodium falciparum merozoite proteins binding to erythrocyte band 3 form a direct complex. , 2005, Biochemical and biophysical research communications.

[5]  S. Herrera,et al.  Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit. , 2005, The American journal of tropical medicine and hygiene.

[6]  C. Withers-Martinez,et al.  Molecular Identification of a Malaria Merozoite Surface Sheddase , 2005, PLoS pathogens.

[7]  S. Puri,et al.  Merozoite Surface Protein 1 of Plasmodium vivax Induces a Protective Response against Plasmodium cynomolgi Challenge in Rhesus Monkeys , 2005, Infection and Immunity.

[8]  M. Grainger,et al.  Precise epitope mapping of malaria parasite inhibitory antibodies by TROSY NMR cross-saturation. , 2005, Biochemistry.

[9]  M. Grainger,et al.  Malaria parasite-inhibitory antibody epitopes on Plasmodium falciparum merozoite surface protein-1(19) mapped by TROSY NMR. , 2004, Molecular and biochemical parasitology.

[10]  A. Holder,et al.  The Fine Specificity, but Not the Invasion Inhibitory Activity, of 19-Kilodalton Merozoite Surface Protein 1-Specific Antibodies Is Associated with Resistance to Malarial Parasitemia in a Cross-Sectional Survey in The Gambia , 2004, Infection and Immunity.

[11]  Virander S. Chauhan,et al.  Comparison of Immunogenicities of Recombinant Plasmodium vivax Merozoite Surface Protein 1 19- and 42-Kilodalton Fragments Expressed in Escherichia coli , 2004, Infection and Immunity.

[12]  Chairat Uthaipibull,et al.  Inhibitory and neutral antibodies to Plasmodium falciparum MSP119 form ring structures with their antigen. , 2004, Molecular and biochemical parasitology.

[13]  Joon-Yong Chung,et al.  Epidermal growth factor-like motifs 1 and 2 of Plasmodium vivax merozoite surface protein 1 are critical domains in erythrocyte invasion. , 2004, Biochemical and biophysical research communications.

[14]  C. John,et al.  Evidence That Invasion-Inhibitory Antibodies Specific for the 19-kDa Fragment of Merozoite Surface Protein-1 (MSP-119) Can Play a Protective Role against Blood-Stage Plasmodium falciparum Infection in Individuals in a Malaria Endemic Area of Africa1 , 2004, The Journal of Immunology.

[15]  A. Holder,et al.  Fine Specificity of Serum Antibodies to Plasmodium falciparum Merozoite Surface Protein, PfMSP-119, Predicts Protection from Malaria Infection and High-Density Parasitemia , 2004, Infection and Immunity.

[16]  Steven S. Oh,et al.  A Co-ligand Complex Anchors Plasmodium falciparum Merozoites to the Erythrocyte Invasion Receptor Band 3* , 2004, Journal of Biological Chemistry.

[17]  A. Holder,et al.  Suramin and Suramin Analogues Inhibit Merozoite Surface Protein-1 Secondary Processing and Erythrocyte Invasion by the Malaria Parasite Plasmodium falciparum* , 2003, Journal of Biological Chemistry.

[18]  H. Bujard,et al.  The Merozoite Surface Protein 1 Complex of Human Malaria Parasite Plasmodium falciparum , 2003, Journal of Biological Chemistry.

[19]  F. Nato,et al.  Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate. , 2003, Journal of molecular biology.

[20]  Steven S. Oh,et al.  Band 3 is a host receptor binding merozoite surface protein 1 during the Plasmodium falciparum invasion of erythrocytes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Patarroyo,et al.  Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments. , 2003, Vaccine.

[22]  D. Garboczi,et al.  Structure of the C-terminal Domains of Merozoite Surface Protein-1 from Plasmodium knowlesi Reveals a Novel Histidine Binding Site* , 2003, The Journal of Biological Chemistry.

[23]  A. Kaneko,et al.  Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Vaidya,et al.  A Multigene Family That Interacts with the Amino Terminus of Plasmodium MSP-1 Identified Using the Yeast Two-Hybrid System , 2002, Eukaryotic Cell.

[25]  A. Holder,et al.  The Human Immune Response to Plasmodium falciparum Includes Both Antibodies That Inhibit Merozoite Surface Protein 1 Secondary Processing and Blocking Antibodies , 2002, Infection and Immunity.

[26]  I. Soares,et al.  Immunogenic properties of the Plasmodium vivax vaccine candidate MSP119 expressed as a secreted non-glycosylated polypeptide from Pichia pastoris , 2002, Parasitology.

[27]  H. Curtidor,et al.  Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes. , 2002, Vaccine.

[28]  T. Daly,et al.  Interaction between two domains of the P. yoelii MSP-1 protein detected using the yeast two-hybrid system. , 2001, Molecular and biochemical parasitology.

[29]  S. Howell,et al.  The 22 kDa component of the protein complex on the surface of Plasmodium falciparum merozoites is derived from a larger precursor, merozoite surface protein 7. , 2001, Molecular and biochemical parasitology.

[30]  C. Ockenhouse,et al.  Purification, Characterization, and Immunogenicity of a Disulfide Cross-Linked Plasmodium vivax Vaccine Candidate Antigen, Merozoite Surface Protein 1, Expressed in Escherichia coli , 2001, Infection and Immunity.

[31]  A. Cowman,et al.  Antibodies against Merozoite Surface Protein (Msp)-119 Are a Major Component of the Invasion-Inhibitory Response in Individuals Immune to Malaria , 2001, The Journal of experimental medicine.

[32]  A. Holder,et al.  Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum. , 2001, Journal of molecular biology.

[33]  E. Davidson,et al.  Identification of a novel antigenic domain of Plasmodium falciparum merozoite surface protein-1 that specifically binds to human erythrocytes and inhibits parasite invasion, in vitro. , 2000, Molecular and biochemical parasitology.

[34]  S. H. Wilson,et al.  Backbone dynamics and refined solution structure of the N-terminal domain of DNA polymerase beta. Correlation with DNA binding and dRP lyase activity. , 2000, Journal of molecular biology.

[35]  A. Holder,et al.  Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1. , 1999, Journal of molecular biology.

[36]  P. Alzari,et al.  Plasmodium falciparum subtilisin-like protease 2, a merozoite candidate for the merozoite surface protein 1-42 maturase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[37]  G. Bentley,et al.  The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate. , 1999, Molecular cell.

[38]  Christian Griesinger,et al.  Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients , 1999 .

[39]  A. Bax,et al.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology , 1999, Journal of biomolecular NMR.

[40]  A. Holder,et al.  Human antibodies to the 19 kDa C‐terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro , 1999, Parasite immunology.

[41]  A. Holder,et al.  Passive Immunization with Antibodies against Three Distinct Epitopes on Plasmodium yoelii Merozoite Surface Protein 1 Suppresses Parasitemia , 1998, Infection and Immunity.

[42]  K. Mendis,et al.  Baculovirus Merozoite Surface Protein 1 C-Terminal Recombinant Antigens Are Highly Protective in a Natural Primate Model for HumanPlasmodium vivax Malaria , 1998, Infection and Immunity.

[43]  A. Holder,et al.  Antibodies that Inhibit Malaria Merozoite Surface Protein–1 Processing and Erythrocyte Invasion Are Blocked by Naturally Acquired Human Antibodies , 1997, The Journal of experimental medicine.

[44]  J. Thornton,et al.  AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.

[45]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[46]  C. Sander,et al.  Dali: a network tool for protein structure comparison. , 1995, Trends in biochemical sciences.

[47]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[48]  K Wüthrich,et al.  The program XEASY for computer-supported NMR spectral analysis of biological macromolecules , 1995, Journal of biomolecular NMR.

[49]  A. Holder,et al.  Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein , 1994, The Journal of experimental medicine.

[50]  T. McCutchan,et al.  Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). , 1993, Molecular and biochemical parasitology.

[51]  H. Whittle,et al.  Processing of the Plasmodium falciparum major merozoite surface protein-1: identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion. , 1991, Molecular and biochemical parasitology.

[52]  A. Holder,et al.  A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion- inhibiting antibodies , 1990, The Journal of experimental medicine.

[53]  M. Perkins,et al.  Chemical crosslinking of Plasmodium falciparum glycoprotein, Pf200 (190-205 kDa), to the S-antigen at the merozoite surface. , 1990, Experimental parasitology.

[54]  T. Daly,et al.  Passive immunization against murine malaria with an IgG3 monoclonal antibody. , 1984, Journal of immunology.

[55]  A. Holder,et al.  Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody , 1982, The Journal of experimental medicine.

[56]  A. Holder,et al.  What is the function of MSP-I on the malaria merozoite? , 1994, Parasitology today.

[57]  A. Holder,et al.  A malaria merozoite surface protein (MSP1)-structure, processing and function. , 1992, Memorias do Instituto Oswaldo Cruz.